Free Live Webinar · Session 5 of 6
Centralized and Risk-Based Monitoring with AI
What you'll take away
- See how sponsors are configuring AI-driven signal detection alongside existing KRIs and QTLs rather than parallel to them
- Understand what the false-positive rate does to CRA workload, and how teams are tuning thresholds against it
- Learn where model-surfaced anomalies belong in the monitoring plan and risk assessment
- Discover what the oversight record needs to show between a flag and an action
- Gain insight into holding CRO accountability when the CRO owns the monitoring platform
- Hear real-world examples of central monitoring programs running AI in production
Save your seat
Free to attend. Can't join live? Register and we'll send the recording.
Access granted
AI in Clinical Trials: What FDA and EMA Now Expect
Our Partners
Sponsored By
Clinical Excellence GmbH is a clinical research consulting and training company specializing in GCP-compliant clinical trial operations.
The panel
Who you'll hear from.
A panel of practitioners who live inside these questions, moderated live with audience Q&A.
Moderator
Jessica Cordes
Senior Consultant
Clinical Excellence
Panelist
Saubiya Kidwai
Vice President of Quality
Signant Health
Panelist
Dr. Selena Baset
Founder & CEO
TraceLine Solutions
Why now
From AI Signals to Monitoring Decisions
E6(R3) asks for risk proportionality and gives you no template for it. Central monitoring teams are using AI to detect site-level anomalies, surface patterns that suggest a protocol comprehension problem, and decide which visits need to happen at all. A signal only matters if someone acts on it, and the gap between a flag being raised and a monitor getting on a plane is exactly what an inspector will ask to see.
Built for
Who should attend.
Built for the people accountable when AI touches a trial, across quality, data, operations, and regulatory.
Central monitoring
RBQM
Clinical Operations
Clinical quality
GCP Compliance
CRO management
The series
Part of AI in Clinical Operations & Clinical Trials.
Six live panels on where artificial intelligence is reshaping clinical trials. Free to attend, and every session recorded.
3
Oct 27, 2026
6
Generative AI for Protocols, CSRs, and Regulatory Narratives
Jan 14, 2027
